Allied Biotech Market Cap

Allied Biotech has a market cap or net worth of 2.51 billion as of March 9, 2026. Its market cap has increased by 47.79% in one year.

Market Cap

2.51B

Enterprise Value

2.46B

Revenue

821.81M

Ranking

n/a

PE Ratio

26.62

Stock Price

26.00

Market Cap Chart

Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.51B, an increase of 97.10%. That is a compound annual growth rate of 4.37%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	2.54B	14.29%
Dec 31, 2025	2.22B	33.44%
Dec 31, 2024	1.67B	5.41%
Dec 29, 2023	1.58B	17.93%
Dec 30, 2022	1.34B	-7.84%
Dec 30, 2021	1.45B	-9.31%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 27, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Johnson Chemical Pharmaceutical Works	2.54B
PhytoHealth	2.71B
Golden Biotechnology	2.26B
Maywufa Company	2.92B
TSH Biopharm Corporation	2.00B
Merdury Biopharmaceutical	3.47B
Easywell Biomedicals	3.62B
LIWANLI Innovation	3.63B

Market Cap Rankings